Edaravone is more than antioxidant in ALS treatment, early study shows
Edaravone, an approved amyotrophic lateral sclerosis (ALS) therapy sold as Radicava and Radicava ORS, may exert neuroprotective effects…
Articles by Steve Bryson, PhD
Neighborhood disadvantage linked to shorter survival time in ALS
Neighborhood disadvantage, or living in regions with poorer socioeconomic conditions, is significantly associated with shorter survival time among people with…
Repeated brain injury quickens ALS onset and progression in mice
Repeated traumatic brain injuries (TBIs), which happen when the brain is damaged by external impacts such as a fall or…
Study: Machine learning uncovers new genes associated with ALS
A machine learning analysis of gene activity in spinal cord samples from people with amyotrophic lateral sclerosis (ALS) revealed…
Study links constipation with faster ALS progression, poorer survival
Constipation, a symptom experienced by about half of amyotrophic lateral sclerosis (ALS) patients, is associated with a significantly faster…
Living next to croplands tied to greater ALS risk, younger onset age
Living next to arable cropland significantly raises the risk of developing amyotrophic lateral sclerosis (ALS), according to a new…
Unlearn to use APST clinical data to create ‘digital twins’ of ALS patients
The technology company Unlearn is teaming up with APST Research to create “digital twins” to support clinical trials…
NP001 seen to extend survival, preserve lung function with ALS
Neuvivo’s investigational therapy NP001 (sodium chlorite), designed to dampen inflammation and restore immune system balance, extended survival in…
Highly targeted approach supports ALS gene therapy development
Researchers have developed a type of gene therapy that can rescue the function of the TDP-43 protein in diseased nerve…
Differences in tears can distinguish bulbar-onset ALS vs. spinal-onset
Differences in tear metabolites — the products of metabolism that are found in human tears — in people with…